knowledge -WSS

knowledge

author：entertainment 2025-09-02 11:34:16 - browse：271

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： What does generative AI mean for health care? We asked experts
Next article： Biden's order seeks to regulate AI risk without stifling innovation

WSS

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Why Sanofi got shellacked over its spinoff

Why are Kaiser Permanente staff considering a strike?

The FDA weighs the risks of candy

Telehealth options flood the market as retailers push virtual care

CDC's new outbreak response network to include Northeastern

focus

knowledge

explore

Continuity nursing helped my family in our darkest PICU moments

EpiPen alternative approval delay highlights citizen petition issue

Drug repurposing or repositioning? The language matters

Hospitals warn Medicare's drug payment fix is ‘unlawful’

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Diversifying clinical trials isn't enough to close racial gaps: study

What does generative AI mean for health care? We asked experts

FDA panel to weigh approval of NurOwn, controversial ALS drug

Affirmative action in medical school literally saved lives

Second xenotransplant done with gene

entertainment

What Congress can do to address the rural doctor shortage

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Eli Lilly to pay $200M for Beam’s stake in gene

Hospitals warn Medicare's drug payment fix is ‘unlawful’

How Vertex's cystic fibrosis drug is changing patients' lives

EpiPen alternative approval delay highlights citizen petition issue

focus

Wikipedia

hotspot

focus